Physician profile
Mitchell R Goldstein
NPI 1922041060
$86,211.46
in general payments reported to CMS, 2019-2025
15 companies · $16K in 2025
The $16K reported for 2025 was more than what 99% of Neonatal-Perinatal Medicine providers received nationally (typical 2025 total: $77.90).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,508 · 2020: $8,391 · 2022: $32K · 2023: $19K · 2024: $2,933 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $34K · Travel and Lodging: $1,205 · Food and Beverage: $1,144 · Consulting Fee: $1,141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $34,002.00 |
| Travel and Lodging | $1,204.53 |
| Food and Beverage | $1,143.77 |
| Consulting Fee | $1,140.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $39,402.38 | 2022-2025 | |
| Pfizer INC. | $25,453.00 | 2022-2023 | |
| Sobi, INC | $13,381.38 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $4,396.20 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $1,550.00 | 2020 | |
| Draeger Medical Systems, INC | $1,500.00 | 2023 | |
| Mallinckrodt Hospital Products INC. | $209.89 | 2020-2022 | |
| Novo Nordisk INC | $116.98 | 2024 | Wegovy |
| Glaxosmithkline, LLC. | $43.66 | 2022 | |
| Mallinckrodt Enterprises LLC | $43.56 | 2019 | |
| Chiesi USA, INC. | $39.73 | 2024 | Curosurf |
| E.R. Squibb & Sons, L.L.C. | $33.96 | 2025 | Cobenfy |
| Boston Scientific Corporation | $23.37 | 2024 | |
| Getinge USA Sales, LLC | $17.35 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Goldstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.